Literature DB >> 11083855

Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice.

E Blessing1, S Nagano, L A Campbell, M E Rosenfeld, C C Kuo.   

Abstract

We have previously demonstrated that Chlamydia pneumoniae accelerates plaque formation in apolipoprotein E-deficient (ApoE(-/-)) mice following intranasal inoculations. In this study, we evaluated the effect of respiratory tract infection with Chlamydia trachomatis on the progression of atherosclerosis in ApoE(-/-) mice. The study showed that in contrast to infection with Chlamydia pneumoniae, infection of the lung and aorta with C. trachomatis was mild and transient and did not significantly accelerate plaque development.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083855      PMCID： PMC97840          DOI： 10.1128/IAI.68.12.7195-7197.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Chlamydia trachomatis confirmatory testing of PCR-positive genitourinary specimens using a second set of plasmid primers.

Authors:  J B Mahony; K E Luinstra; D Jang; J Sellors; M A Chernesky
Journal:  Mol Cell Probes       Date:  1992-10       Impact factor: 2.365

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test.

Authors:  S P Wang; J T Grayston
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

4.  Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection.

Authors:  Y Fan; S Wang; X Yang
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  T C Moazed; L A Campbell; M E Rosenfeld; J T Grayston; C C Kuo
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

6.  Interaction of Chlamydia trachomatis organisms and HeLa 229 cells.

Authors:  C C Kuo; T Grayston
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

7.  Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice.

Authors:  E Blessing; T M Lin; L A Campbell; M E Rosenfeld; D Lloyd; C Kuo
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

9.  A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.

Authors:  Z P Yang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  A mouse model of Chlamydia trachomatis pneumonitis.

Authors:  C Kuo; W J Chen
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226
View more
  11 in total

1.  Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Authors:  K Burian; K Berencsi; V Endresz; Z Gyulai; T Valyi-Nagy; I Valyi-Nagy; M Bakay; Y Geng; D Virok; L Kari; R Hajnal-Papp; G Trinchieri; E Gonczol
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.

Authors:  Rosalinda Sorrentino; Atilla Yilmaz; Katja Schubert; Timothy R Crother; Aldo Pinto; Kenichi Shimada; Moshe Arditi; Shuang Chen
Journal:  Cell Immunol       Date:  2015-01-30       Impact factor: 4.868

3.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Authors:  Lee Ann Campbell; Mirja Puolakkainen; Amy Lee; Michael E Rosenfeld; H Jacques Garrigues; Cho-Chou Kuo
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

5.  Chlamydia pneumoniae infection-induced endoplasmic reticulum stress causes fatty acid-binding protein 4 secretion in murine adipocytes.

Authors:  Nirwana Fitriani Walenna; Yusuke Kurihara; Bin Chou; Kazunari Ishii; Toshinori Soejima; Kenji Hiromatsu
Journal:  J Biol Chem       Date:  2020-01-28       Impact factor: 5.157

6.  Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1.

Authors:  Lee A Campbell; Amy W Lee; Michael E Rosenfeld; Cho-Chou Kuo
Journal:  Pathog Dis       Date:  2013-10-01       Impact factor: 3.166

7.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

Review 8.  Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.

Authors:  Satoru Hirono; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

9.  Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.

Authors:  Victoria L M Herrera; Li Shen; Lyle V Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

10.  TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Authors:  Yoshikazu Naiki; Rosalinda Sorrentino; Michelle H Wong; Kathrin S Michelsen; Kenichi Shimada; Shuang Chen; Atilla Yilmaz; Anatoly Slepenkin; Nicolas W J Schröder; Timothy R Crother; Yonca Bulut; Terence M Doherty; Michelle Bradley; Zory Shaposhnik; Ellena M Peterson; Peter Tontonoz; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.